(Q40454080)

20 September 2017

title

Inhibition of human telomerase by oligonucleotide chimeras, composed of an antisense moiety and a chemically modified homo-oligonucleotide. (English)

1 reference

Evelyne Ségal-Bendirdjian

20 September 2017

Istvan Szatmari

3

0 references

object named as

Evelyne Ségal-Bendirdjian

7

0 references

author name string

Ilona Tarkanyi

1

1 reference

20 September 2017

András Horváth

2

1 reference

20 September 2017

Helga Eizert

4

1 reference

20 September 2017

György Vámosi

5

1 reference

20 September 2017

Sándor Damjanovich

6

1 reference

20 September 2017

Janos Aradi

8

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

20 September 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

FEBS Letters

1 reference

20 September 2017

volume

579

1 reference

20 September 2017

issue

6

1 reference

20 September 2017

page(s)

1411-1416

1 reference

The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.041

Telomerase: biochemical considerations for enzyme and substrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.041

Specific Association of Human Telomerase Activity with Immortal Cells and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.041

Telomerase contributes to tumorigenesis by a telomere length-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.041

Natural and pharmacological regulation of telomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.041

Telomerase protein rather than its RNA is the target of phosphorothioate-modified oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.041

Specific inhibition of human telomerase activity by transfection reagent, FuGENE6-antisense phosphorothioate oligonucleotide complex in HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.041

Inhibition of human telomerase activity by peptide nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.041

Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.041

Inhibition of telomerase by 2'-O-(2-methoxyethyl) RNA oligomers: effect of length, phosphorothioate substitution and time inside cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.041

(s4dU)35: a novel, highly potent oligonucleotide inhibitor of the human immunodeficiency virus type 1 reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.041

Amplification and enhanced expression of the epidermal growth factor receptor gene in A431 human carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.041

Telomerase catalytic subunit homologs from fission yeast and human

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.041

Negative regulation of yeast telomerase activity through an interaction with an upstream region of the DNA primer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.041

Effective intracellular delivery of oligonucleotides in order to make sense of antisense

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.041

Significance of immunological detection of human telomerase reverse transcriptase: re-evaluation of expression and localization of human telomerase reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.01.041

10.1016/J.FEBSLET.2005.01.041

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference